RESUMEN
Pre- as well as post-exposure prophylaxis plays an important role in controlling the number of deaths associated with human rabies. Rabies vaccines, classically injected intramuscularly, are now also administered by intradermal (ID) route. Vaccines to be administered by the ID route should meet the same quality, safety and efficacy specifications as vaccines for intramuscular (IM) use. The aim of this paper is to provide information based on publicly available data regarding the ID use of rabies vaccines and to identify potential needs for further analysis of the potency, immunogenicity and effectiveness of rabies vaccines administered by this route. A first literature search, focused on the immunogenicity of rabies vaccines given by ID route, identified 338 publications in the period 1997-2018, 40 of which were included in our analyses. A second search investigating the effectiveness of ID vaccination resulted in 371 hits for the period 2007-2018, of which 13 suitable publications were retained. The immunogenicity of current rabies vaccines was analyzed in 3 ways: proportion of subjects reaching the antibody threshold of 0.5â¯IU/ml after ID vaccination, relationship between potency and immunogenicity of the vaccine given intradermally, and comparison of antibody responses after IM or ID vaccination. Overall, vaccines administered intradermally were found immunogenic. Post-exposure prophylaxis by ID route appeared at least as immunogenic as by IM regimens. By contrast, ID pre-exposure prophylaxis trended towards lower antibody titers than IM vaccination, but the observation was not associated with any clinical relevance. Vaccine effectiveness was assessed by investigating survival after exposure. Data from more than 30,000 patients who sought rabies post-exposure prophylaxis did not indicate that current vaccines administered by ID route lack efficacy. These results support current recommendations for ID vaccination against rabies. However, published data on ID performance were associated with significant weaknesses that future research should better address.
Asunto(s)
Vacunas Antirrábicas/administración & dosificación , Vacunas Antirrábicas/inmunología , Rabia/prevención & control , Anticuerpos Antivirales/sangre , Formación de Anticuerpos , Humanos , Inyecciones Intradérmicas , Resultado del Tratamiento , Potencia de la VacunaRESUMEN
Eight candidate housekeeping genes were examined as internal controls for normalizing expression analysis of durum wheat (Triticum durum L.) under drought and salinity stress conditions. Quantitative real-time PCR was used to analyse gene expression of multiple stress levels, plant ages (24 and 50 days old), and plant tissues (leaf and root). The algorithms BestKeeper, NormFinder, GeNorm, the delta Ct method and the RefFinder were applied to determine the stability of candidate genes. Under drought stress, the most stable reference genes were glyceraldehyde-3 phosphate, ubiquitin and ß-tubulin2, whereas under salinity stress conditions, eukaryotic elongation factor 1-α, glyceraldehyde-3 phosphate and actin were identified as the most stable reference genes. Validation with stress-responsive genes NAC29 and NAC6 demonstrated that the expression level of target genes could be determined reliably with combinations of up to three of the reference genes. This is the first report on reference genes appropriate for quantification of target gene expression in T. durum under drought and salt stresses. Results of this investigation may be applicable to other Triticum species.
Asunto(s)
Perfilación de la Expresión Génica/métodos , Regulación de la Expresión Génica de las Plantas , Genes Esenciales/genética , Genes de Plantas/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa/métodos , Triticum/genética , Algoritmos , Sequías , Perfilación de la Expresión Génica/normas , Estándares de Referencia , Reproducibilidad de los Resultados , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa/normas , Estrés Salino , Estrés FisiológicoRESUMEN
Rabies is a life-threatening neglected tropical disease: tens of thousands of cases are reported annually in endemic countries (mainly in Africa and Asia), although the actual numbers are most likely underestimated. Rabies is a zoonotic disease that is caused by infection with viruses of the Lyssavirus genus, which are transmitted via the saliva of an infected animal. Dogs are the most important reservoir for rabies viruses, and dog bites account for >99% of human cases. The virus first infects peripheral motor neurons, and symptoms occur after the virus reaches the central nervous system. Once clinical disease develops, it is almost certainly fatal. Primary prevention involves dog vaccination campaigns to reduce the virus reservoir. If exposure occurs, timely post-exposure prophylaxis can prevent the progression to clinical disease and involves appropriate wound care, the administration of rabies immunoglobulin and vaccination. A multifaceted approach for human rabies eradication that involves government support, disease awareness, vaccination of at-risk human populations and, most importantly, dog rabies control is necessary to achieve the WHO goal of reducing the number of cases of dog-mediated human rabies to zero by 2030.
Asunto(s)
Rabia/complicaciones , Rabia/diagnóstico , Animales , Mordeduras y Picaduras/complicaciones , Mordeduras y Picaduras/virología , Enfermedades de los Perros/epidemiología , Enfermedades de los Perros/virología , Perros/virología , Humanos , Profilaxis Posexposición/métodos , Rabia/fisiopatología , Vacunas Antirrábicas/uso terapéutico , Virus de la Rabia/patogenicidad , Zoonosis/complicaciones , Zoonosis/etiologíaRESUMEN
An increasing number of dog bite victims were being presented to public hospitals in Himachal Pradesh in 2014 amidst virtual non availability of any rabies immunoglobulin (RIG). Only a small quantity of equine rabies immunoglobulin (eRIG) was available from the government owned Central Research Institute (CRI) Kasauli. This available eRIG was used in 269 patients as an emergency response and only for local infiltration of severe bite wounds by suspected rabid dogs. This was followed by rabies vaccination, using the WHO approved intra-dermal Thai Red Cross Society vaccination schedule. A subgroup of 26 patients were later identified who had been severely bitten by laboratory confirmed rabid dogs. They were followed for more than one year and all were found to be alive.
Asunto(s)
Anticuerpos Antivirales/administración & dosificación , Factores Inmunológicos/administración & dosificación , Inmunoterapia/métodos , Rabia/prevención & control , Heridas y Lesiones/tratamiento farmacológico , Adolescente , Adulto , Animales , Anticuerpos Antivirales/economía , Mordeduras y Picaduras/complicaciones , Niño , Preescolar , Perros , Femenino , Humanos , Factores Inmunológicos/economía , Inmunoterapia/economía , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Vacunas Antirrábicas/administración & dosificación , Vacunas Antirrábicas/inmunología , Resultado del Tratamiento , Adulto JovenAsunto(s)
Países en Desarrollo , Accesibilidad a los Servicios de Salud/economía , Profilaxis Posexposición , Áreas de Pobreza , Rabia/mortalidad , Animales , Reservorios de Enfermedades , Vectores de Enfermedades/clasificación , Enfermedades de los Perros/prevención & control , Enfermedades de los Perros/transmisión , Enfermedades de los Perros/virología , Perros , Accesibilidad a los Servicios de Salud/estadística & datos numéricos , Humanos , Profilaxis Posexposición/economía , Profilaxis Posexposición/estadística & datos numéricos , Rabia/diagnóstico , Rabia/prevención & control , Rabia/terapiaRESUMEN
BACKGROUND: Herpes simplex virus (HSV) is the most common cause of sporadic encephalitis worldwide. The high mortality rate (70-80 %) of herpes simplex encephalitis (HSE) can be reduced to 20-30 % by antiviral therapy. However, normocellular CSF can lure physicians to look for non-infectious causes, resulting in delayed treatment. This study aimed to investigate, characterize and differentiate HSE patients, with normocellular and pleocytosis CSF, according to neuroimaging patterns, underlying disease, CSF viral load and clinical outcome. Patients with proven (by PCR positive CSF) or presumed viral infections of the CNS admitted to King Chulalongkorn Memorial Hospital between January 2002 and 2011 were analyzed. RESULTS: HSV was detected in the CSF of 43 patients but only 23 patients had encephalitis. Among these 23 patients, 6 cases (26.1 %) had normal CSF WBC (<5 cells/mm(3)). One patient in this normocellular CSF group had HIV infection. Although this patient had low CD4 counts (<200 cells/mm(3)), the peripheral WBC counts showed only mild leukopenia. The CSF HSV viral load in the pleocytosis group was higher than the normocellular group, with an average of 12,200 vs 3027 copies/ml respectively. There was no correlation between the viral load and the clinical outcome. With respect to neuroimaging, 4 (66.7 %) patients in the normocellular group had unremarkable/non-specific results. CONCLUSIONS: Normocellular CSF in HSE is not rare, and can be seen in normal as well as immunocompromised hosts. Clinicians should not exclude CNS infection, especially HSE, merely based on the absence of CSF pleocytosis and/or unremarkable neuroimaging study.
Asunto(s)
Encefalitis por Herpes Simple/líquido cefalorraquídeo , Encefalitis por Herpes Simple/patología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Niño , Preescolar , Demografía , Encefalitis por Herpes Simple/complicaciones , Femenino , Humanos , Lactante , Leucocitosis/complicaciones , Leucocitosis/patología , Masculino , Persona de Mediana Edad , Adulto JovenRESUMEN
The World Health Organization reports that over 60,000 humans die of rabies annually, worldwide. Most occur in remote regions of developing countries. Almost all victims received no postexposure rabies prophylaxis (PEP). There are no facilities or health personnel able to provide it in many areas where the disease is prevalent. A first approach to correct this problem would be by extending provision of modern PEP to areas where human rabies is most prevalent.
Asunto(s)
Mordeduras y Picaduras/complicaciones , Accesibilidad a los Servicios de Salud , Profilaxis Posexposición/métodos , Rabia/prevención & control , Salud Global , Humanos , Rabia/epidemiología , Rabia/mortalidadAsunto(s)
Antibacterianos/uso terapéutico , Mordeduras y Picaduras , Haplorrinos , Vacunas Antirrábicas/uso terapéutico , Rabia , Viaje , Infección de Heridas , Adolescente , Animales , Mordeduras y Picaduras/complicaciones , Mordeduras y Picaduras/diagnóstico , Mordeduras y Picaduras/fisiopatología , Mordeduras y Picaduras/terapia , Manejo de la Enfermedad , Encefalitis Viral/etiología , Encefalitis Viral/prevención & control , Femenino , Humanos , Rabia/etiología , Rabia/prevención & control , Factores de Riesgo , Tétanos/etiología , Tétanos/prevención & control , Infección de Heridas/tratamiento farmacológico , Infección de Heridas/etiologíaRESUMEN
Since the end of the Vietnam War and increasing tourism to Asia, there has been ongoing reverse migration of Westerners to Southeast Asia. Some, but not all, have pensions and modest assets. Some acquire a locals spouse and raise a second family. Many of those who arrived early are now aging rapidly and are depleting their financial resources. Health problems become socio/economic threats. None of the Asian target countries that attract reverse migrants have adequate health care and social safety nets that are available to them. The usual health care safety nets expected in western countries do not cover their nationals in a foreign country. This essay discusses these problems as seen from the perspective of two practicing physicians in Southeast Asia.
Asunto(s)
Atención a la Salud , Emigrantes e Inmigrantes/psicología , Emigrantes e Inmigrantes/estadística & datos numéricos , Medicina del Viajero , Asia Sudoriental , Femenino , Humanos , Seguro de Salud , Masculino , Factores Socioeconómicos , Tailandia , VietnamRESUMEN
BACKGROUND: Data on encephalitis in Thailand have not been completely described. Etiologies remain largely unknown. We prospectively analyzed 103 Thai patients from 27 provinces for the causes of encephalitis using clinical, microbiological and neuroimaging indices; caseswithout a diagnosis were evaluated for autoimmune causes of encephalitis. METHODS: Patients with encephalitis and/or myelitis were prospectively studied between October 2010 and August 2012. Cases associated with bacterial, rickettsial and mycobacterial diseases were excluded. Herpes viruses 1-6 and enteroviruses infection was diagnosed using PCR evaluation of CSF; dengue and JE viruses infection, by serology. The serum of test-negative patients was evaluated for the presence of autoantibodies. RESULTS: 103 patients were recruited. Fifty-three patients (52%) had no etiologies identified. Twenty-five patients (24%) were associated with infections. Immune encephalitis was found in 25 (24%); neuropsychiatric lupus erythematosus (4), demyelinating diseases (3), Behcet's disease (1) and the remaining had antibodies to NMDAR (5), ANNA-2 (6), Yo (2), AMPA (1), GABA (1), VGKC (1) and NMDA coexisting with ANNA-2 (1). Presenting symptoms in the autoimmune group included behavioral changes in 6/25 (versus 12/25 in infectious and 13/53 in unknown group) and as psychosis in 6/25 (versus 0/25 infectious and 2/53 unknown). Seizures were found in 6/25 autoimmune, 4/25 infectious and 19/53 unknown group. Two patients with anti-ANNA-2 and one anti-Yo had temporal lobe involvement by magnetic resonance imaging. Two immune encephalitis patients with antibodies to NMDAR and ANNA-2 had ovarian tumors. CONCLUSIONS: Autoantibody-associated encephalitis should be considered in the differential diagnosis and management algorithm regardless of clinical and neuroimaging features.
Asunto(s)
Autoanticuerpos/sangre , Encefalopatías/sangre , Encefalopatías/epidemiología , Enfermedad de Hashimoto/sangre , Enfermedad de Hashimoto/epidemiología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Encefalopatías/diagnóstico , Niño , Preescolar , Encefalitis/sangre , Encefalitis/diagnóstico , Encefalitis/epidemiología , Femenino , Enfermedad de Hashimoto/diagnóstico , Humanos , Lactante , Recién Nacido , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Tailandia/epidemiología , Adulto JovenRESUMEN
Polymerase chain reaction was used to detect Leishmania siamensis DNA from clinical samples collected from six leishmaniasis patients during 2011-2012. The samples used in this study came from bone marrow, blood, buffy coat, saliva, urine, and tissue biopsy specimens. Saliva was a good source for L. siamensis DNA by polymerase chain reaction. L. siamensis DNA was also found in saliva of an asymptomatic case-patient. Levels of L. siamensis DNA in saliva decreased until being undetectable after treatment. These levels could be used as a marker to evaluate efficacy of the treatment. A larger study is needed to evaluate this method as a screening and survey tool to study the silent background of Leishmania infection among the at-risk population.
Asunto(s)
ADN Protozoario/genética , Leishmania/genética , Leishmaniasis Visceral/diagnóstico , Saliva/parasitología , Adulto , Secuencia de Aminoácidos , Antiprotozoarios/uso terapéutico , Biomarcadores/metabolismo , ADN Protozoario/aislamiento & purificación , Femenino , Humanos , Leishmania/aislamiento & purificación , Leishmaniasis Visceral/tratamiento farmacológico , Leishmaniasis Visceral/parasitología , Masculino , Persona de Mediana Edad , Datos de Secuencia Molecular , Reacción en Cadena de la PolimerasaAsunto(s)
Profilaxis Posexposición/métodos , Vacunas Antirrábicas/administración & dosificación , Rabia/prevención & control , Medicina del Viajero , Alaska , Animales , Animales Salvajes , Anticuerpos Antivirales/inmunología , Asia , Mordeduras y Picaduras/virología , Gatos , Perros , Humanos , Profilaxis Posexposición/normas , Rabia/inmunología , Vacunas Antirrábicas/inmunologíaRESUMEN
Rabies remains a constant threat to humans throughout much of Asia. The dog is the main reservoir and vector with wildlife playing a very minor role. No Asian country or region has been declared rabies free by WHO in over two decades and there is evidence of canine rabies spread to new regions during the past 10 years. We now have the knowledge and technology to control canine rabies. The main barrier in managing this costly endemic is lack of motivation by authorities to address this issue along with regional inability of public health and livestock (agriculture) officials to tackle this issue in cooperation and coordination. Rabies is one of the first recognized zoonoses and a model for a true "One Health" management goal where human; veterinary, and government officials must work together in harmony to defeat this disease.
Asunto(s)
Enfermedades Transmisibles Emergentes/prevención & control , Rabia/prevención & control , Zoonosis/prevención & control , Animales , Asia , Enfermedades Transmisibles Emergentes/transmisión , Perros , Humanos , Rabia/diagnóstico , Rabia/terapia , Rabia/transmisión , Zoonosis/diagnóstico , Zoonosis/terapia , Zoonosis/transmisiónAsunto(s)
Profilaxis Posexposición/métodos , Rabia/prevención & control , Femenino , Humanos , MasculinoRESUMEN
We performed an abbreviated prospective study of rabies pre-exposure (PREP) vaccination in 109 volunteers. Group 1, the control group, received the conventional 3 intradermal injections on days 0, 7 and 21. Group 2 received one rabies vaccine injection (0.1 ml intradermally) at 2 sites on a single day. Group 3 was given one full ampule intramuscularly. One year later, all 3 groups received booster injections (0.1 ml at 4 sites) intradermally at one time or 2 injections intramuscularly on days 0 and 3. All subjects achieved a vigorous anamnestic antibody response 7 days after the boosters. These data suggest that one time immunization of one full dose intramuscularly or 2 site injections of 0.1 intradermally on a single day are adequate to prime immune memory and obtain an accelerated immune response one year later.
Asunto(s)
Vacunas Antirrábicas/administración & dosificación , Vacunas Antirrábicas/inmunología , Rabia/prevención & control , Vacunación/métodos , Adolescente , Adulto , Atención Ambulatoria , Animales , Anticuerpos Antivirales/sangre , Femenino , Experimentación Humana , Humanos , Memoria Inmunológica , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Adulto JovenRESUMEN
Human rabies is essentially a fatal disease once clinical signs develop. Rabies postexposure prophylaxis (PEP) consists of thorough wound care in combination with administration of rabies immunoglobulin and rabies vaccine. This is highly effective in rabies prevention if carried out diligently. Preexposure rabies prophylaxis simplifies PEP in the event of an exposure by eliminating the need for immunoglobulin. Shortened and more convenient and economical PEP regimens are being developed with promising results. They reduce the cost of PEP as well as travel expenses for the often very poor patients. The intradermal PEP regimen can now reduce the vaccine cost by ~60-70%. Although PEP in humans can prevent death, controlling the canine vector by sustained vaccination remains the mainstay of rabies elimination.
Asunto(s)
Profilaxis Posexposición/métodos , Rabia/prevención & control , Países en Desarrollo , Humanos , Inmunoglobulinas/administración & dosificación , Profilaxis Posexposición/economía , Vacunas Antirrábicas/administración & dosificaciónRESUMEN
Many cost-benefit/effective rabies research projects need to be carried out in less-developed canine-endemic regions. Among these are educational approaches directed at the public and governments. They would address effective primary wound care, availability, and proper use of vaccines and immunoglobulins, better reporting of rabies, final elimination of dangerous nerve tissue-derived vaccines, and the recognition that rabies is still expanding its geographic range. Such efforts could also reduce deaths in victims who had received no or less than adequate postexposure prophylaxis. There is a need for new technology in canine population control and sustainable vaccination. We have virtually no workable plans on how to control bat rabies, particularly that from hematophagous bats. Preexposure vaccination of villagers in vampire rabies-endemic regions may be one temporary solution. Current efforts to reduce further the time required and vaccine dose required for effective postexposure vaccination need to be encouraged. We still have incomplete understanding of the transport channels from inoculation site to rabies virus antibody generating cells. The minimum antigen dose required to achieve a consistently protective and lasting immune response has been established for intramuscular vaccine administration, but is only estimated for intradermal use. Greater knowledge may have clinical benefits, particularly in the application of intradermal reduced dose vaccination methods. Curing human rabies is still an unattained goal that challenges new innovative researchers.